Cargando…
The progress of microenvironment-targeted therapies in brain metastases
The incidence of brain metastases (BrM) has become a growing concern recently. It is a common and often fatal manifestation in the brain during the end-stage of many extracranial primary tumors. Increasing BrM diagnoses can be attributed to improvements in primary tumor treatments, which have extend...
Autores principales: | Long, Lifu, Yi, Zhenjie, Zeng, Yu, Liu, Zhixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086249/ https://www.ncbi.nlm.nih.gov/pubmed/37056723 http://dx.doi.org/10.3389/fmolb.2023.1141994 |
Ejemplares similares
-
CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021) -
Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
por: Khan, Safir Ullah, et al.
Publicado: (2023) -
Current Advances and Challenges in Radiomics of Brain Tumors
por: Yi, Zhenjie, et al.
Publicado: (2021) -
Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy
por: Sarandi, Evangelia, et al.
Publicado: (2023) -
Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment
por: Bao, Qianqian, et al.
Publicado: (2022)